NASDAQ
BioCryst Pharmaceuticals, Inc. (BCRX) has a current ratio of 2.06x as of Tuesday, May 26, 2026. This represents a 49.36% decrease compared to its 12-month average of 4.07x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.